Explore a little further

market news

Stories and perspectives from Daytrade News.

From Daytrade News

12 stories shown · Newest added
Daytrade News

Olema Pharmaceuticals Shares Drop 15.1% After AstraZeneca Trial Results

Olema Pharmaceuticals experienced a significant decline in its stock price following AstraZeneca's announcement that its Phase 3 SERENA-4 trial did not meet its primary endpoint. This news has raised concerns among investors regarding Olema's lead candidate, palazestrant, which…

More perspectives

Across our publications

A selection of related stories